Selective Serotonin Reuptake Inhibitors and Pulmonary Arterial Hypertension

Hoeper MM, Humbert M. The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally! Eur Respir J. 2019 Mar 28;53(3):1900038.

Humbert M, Kovacs G, Hoeper M et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2022 Oct;43(38):3618-3731

Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015 Oct;46(4):903-75.

McLaughlin VV, Shah SJ, Souza R, et al. Management of pulmonary arterial hypertension. J Am Coll Cardiol no;65(18):1976–97

Yuichiro J.S, Regina M, Chia C.T, et al. Activation of GATA-4 by Serotonin in Pulmonary Artery Smooth Muscle Cells. THE JOURNAL OF BIOLOGICAL CHEMISTRY 2003 Vol. 278, No. 19, Issue of May 9, pp. 17525–17531.

Philipe H, Jean-Marie L, Marie-Laurkne S. Increased Plasma Serotonin in Primary Pulmonary Hypertension. The American Journal of Medicine September 1995- 99

Mallay O, Setareh Salehi O, Margaret A Persistent Pulmonary Hypertension of the Newborn and Selective Serotonin Reup take Inhibitors Am J Psychiatry 2012;69:134–140

Steven M. K, Evelyn M. H, Ketevan K. B. Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulmonary Pharmacology & Therapeutics 19 (2006) 370–374

Irfan A. D, David N. J, Tara Gomes. Selective Serotonin Reuptake Inhibitors and Pulmonary Arterial Hypertension CHEST 2012; 141(2):348–353

Ali S, Kari E. R, Ioana R. P. Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Pulmonary Arterial Hypertension. CHEST 2013; 144(2):531–541

Claire K. S. M, Justin F. C, Cheryl M. et al. SSRIs: Applications in inflammatory lung disease andimplications for COVID-19 Neuropsychopharmacology Reports. 2021;00:1–11

David L. H, Samia R. T, Peter J, et al. Depression and cardiovascular disease: a clinical review European Heart Journal (2014) 35, 1365–1372 doi:10.1093/eurheartj/eht462